02/02/22 By Li Lucy Brandt
Kids five years and younger might be eligible for COVID vaccines by the end of February. Pediatric COVID cases have been surging while children under five are the only group in the United States not authorized for any COVID vaccine.
While the FDA has authorized 30 microgram doses of the vaccine for adults, and 10 microgram doses for children over six, Pfizer is now testing three microgram doses for kids between the ages of six months and five years old. This low dosage might require children to get three doses of the vaccine, instead of the standard two.
Pfizer has initiated a rolling submission of data to the Food and Drug Administration (FDA) and the vaccine advisory committee is set to meet on Feb. 15. The news comes as a relief to parents who have been waiting for vaccines for their children for two years now. It is estimated that there are about 19.5 million children under five in the United States.
The FDA is expected to sign off on a two-dose vaccine first and the more effective three-dose vaccine later. This will get parents the chance to start getting their children vaccinated while the three-dose regimen is still under review. Pfizer is hopeful to start the vaccine roll-out by the end of February.